12 Best Short Squeeze Stocks to Buy Right Now

Page 6 of 12

7. Viking Therapeutics, Inc. (NASDAQ:VKTX)

short % of float: 22.01%

Number of Hedge Fund Holders: 37

Viking Therapeutics, Inc. (NASDAQ:VKTX) ranks among the best short squeeze stocks to buy right now. On November 20, H.C. Wainwright retained its Buy rating and $102 price target for Viking Therapeutics, Inc. (NASDAQ:VKTX) following the end of enrollment in the company’s VANQUISH-1 obesity trial.

The trial, which enrolled around 4,650 individuals, concluded ahead of schedule and will compare three different doses to a placebo over a 78-week period. VANQUISH-2, the company’s second trial, which aims to enroll around 1,100 people with type 2 diabetes who happen to be obese or overweight, is still enrolling and is expected to be completed in the first quarter of 2026.

Viking Therapeutics, Inc. (NASDAQ:VKTX) also released exploratory analysis data from its Phase 2 VENTURE trial at ObesityWeek 2025 on November 6, demonstrating significant improvements in cardiometabolic measures among obese patients. Notably, 78% of prediabetic individuals who received VK2735 had normal glycemic control after 13 weeks, as opposed to 29% in the placebo group.

Viking Therapeutics, Inc. (NASDAQ:VKTX) is a clinical-stage biopharma company developing treatments for metabolic and endocrine disorders, including obesity, NASH, and rare diseases like X-linked adrenoleukodystrophy (X-ALD).

Page 6 of 12